NCT01593865

Brief Summary

The present study hypothesizes that the systematic use of bilateral internal mammary artery (BIMA) grafting is feasible in the practice of a University Cardiac Surgery Institution for the treatment of multivessel coronary artery disease (primary hypothesis). The secondary study hypothesis is that the BIMA grafting meets the safety endpoint compared with the conventional surgical strategy entailing left mammary artery grafting plus great saphenous vein grafts to revascularize the remaining coronary targets. The tertiary study hypothesis is that the BIMA grafting yields better follow-up results in terms of recurrence of symptoms related to coronary disease, of repeat revascularization and of cardiac mortality compared with patients treated with the conventional surgical strategy entailing left mammary artery grafting plus great saphenous vein grafts to revascularize the remaining coronary targets.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,000

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2012

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

May 5, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 8, 2012

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2014

Completed
Last Updated

August 21, 2012

Status Verified

August 1, 2012

Enrollment Period

2.2 years

First QC Date

May 5, 2012

Last Update Submit

August 17, 2012

Conditions

Keywords

Coronary Artery Bypass GraftingMammary Artery GraftsBilateral Mammary Artery GraftingClinical Outcomes

Outcome Measures

Primary Outcomes (1)

  • Feasibility of systematic BIMA grafting

    Starting in June 2012, all clinical data concerning patients undergoing BIMA grafting are recorded, including the baseline demographics and risk factors, the operative time, all in-hospital complications, duration of Intensive care Unit and Hospital stays, the amount of transfusion of blood products.

    2012-2014 (2 years)

Secondary Outcomes (1)

  • Clinical results at follow-up

    2012-2016 (4 years)

Study Arms (2)

BIMA Grafting Group

Group consists of patients who received bilateral internal mammary artery grafting for treatment of severe coronary disease since June 2012.

Procedure: BIMA Grafting

Control Group

This Group consists of historical control patients who received conventional coronary artery bypass grafting (left mammary artery graft only plus great saphenous vein grafts) in the 2010-2012 period, and who are propensity-matched to the BIMA Group patients.

Procedure: Left-only mammary artery grafting

Interventions

BIMA GraftingPROCEDURE

Both the left and the right internal mammary arteries are harvested and used to revascularize the two major coronary targets. Further coronary targets may be revascularized using either great saphenous vein or radial artery grafts, if present.

BIMA Grafting Group

These patients had only the left mammary artery harvested and used to revascularize the major coronary target. Great saphenous vein grafts and/or radial artery grafts were employed to revascularize the remaining targets.

Control Group

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The target study population consists of 1,000 patients undergoing isolated coronary surgery for multivessel disease within a Cardiac Surgery University Department.

You may qualify if:

  • Patiens undergoing primary or elective-urgent isolated multivessel Coronary Artery Bypass Grafting (CABG) Surgery

You may not qualify if:

  • Emergency status
  • Previous cardiac operation
  • Any associated cardiac procedure other than CABG Surgery
  • Left Ventricular Ejection Fraction \<20%

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Policlinico Universitario "A. Gemelli"

Rome, Italy, 00168, Italy

RECRUITING

Study Officials

  • Massimo Massetti, MD

    Division of Cardiac Surgery, Catholic University

    STUDY DIRECTOR

Central Study Contacts

Massimo Massetti, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher at Cardiac Surgery University Department

Study Record Dates

First Submitted

May 5, 2012

First Posted

May 8, 2012

Study Start

April 1, 2012

Primary Completion

June 1, 2014

Last Updated

August 21, 2012

Record last verified: 2012-08

Locations